Cargando…

Case report : contexte sanitaire Covid-19, un risque supplémentaire d’erreur médicamenteuse ?

INTRODUCTION: A medication error occurred in a recently reorganized hospital department as a result of the Covid-19 outbreak. CASE REPORT: Case of a patient who received a treatment not intended for him, with no clinical consequence. The objective of our study is to identify and analyse the causes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbes, M., Lo Presti, C., Bambina, E., Aghazarian, V., Honoré, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092491/
http://dx.doi.org/10.1016/j.phclin.2021.04.010
_version_ 1783687660228837376
author Abbes, M.
Lo Presti, C.
Bambina, E.
Aghazarian, V.
Honoré, S.
author_facet Abbes, M.
Lo Presti, C.
Bambina, E.
Aghazarian, V.
Honoré, S.
author_sort Abbes, M.
collection PubMed
description INTRODUCTION: A medication error occurred in a recently reorganized hospital department as a result of the Covid-19 outbreak. CASE REPORT: Case of a patient who received a treatment not intended for him, with no clinical consequence. The objective of our study is to identify and analyse the causes of this adverse event. METHODS: The error was reported internally and a post systemic analysis using the REMED method was performed. RESULTS: The analysis of the medication error revealed several contributing factors, including the recent reorganization of the service following the health context. DISCUSSION: Medication error may be due to the systemic organization of the patient's medication management process: factors related to the patient, organization and management, operational practices and procedures, and the healthcare professional. CONCLUSION: Among the improvement actions a review of the location of the pharmacy within the department, a transport of patients with reduced mobility to it for the administration of treatments and a reminder to registered nurses to deblister pharmaceuticals at the time of administration were proposed.
format Online
Article
Text
id pubmed-8092491
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Masson SAS.
record_format MEDLINE/PubMed
spelling pubmed-80924912021-05-03 Case report : contexte sanitaire Covid-19, un risque supplémentaire d’erreur médicamenteuse ? Abbes, M. Lo Presti, C. Bambina, E. Aghazarian, V. Honoré, S. Le Pharmacien Clinicien Article Original INTRODUCTION: A medication error occurred in a recently reorganized hospital department as a result of the Covid-19 outbreak. CASE REPORT: Case of a patient who received a treatment not intended for him, with no clinical consequence. The objective of our study is to identify and analyse the causes of this adverse event. METHODS: The error was reported internally and a post systemic analysis using the REMED method was performed. RESULTS: The analysis of the medication error revealed several contributing factors, including the recent reorganization of the service following the health context. DISCUSSION: Medication error may be due to the systemic organization of the patient's medication management process: factors related to the patient, organization and management, operational practices and procedures, and the healthcare professional. CONCLUSION: Among the improvement actions a review of the location of the pharmacy within the department, a transport of patients with reduced mobility to it for the administration of treatments and a reminder to registered nurses to deblister pharmaceuticals at the time of administration were proposed. Elsevier Masson SAS. 2022-03 2022-02-28 /pmc/articles/PMC8092491/ http://dx.doi.org/10.1016/j.phclin.2021.04.010 Text en © 2021 Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article Original
Abbes, M.
Lo Presti, C.
Bambina, E.
Aghazarian, V.
Honoré, S.
Case report : contexte sanitaire Covid-19, un risque supplémentaire d’erreur médicamenteuse ?
title Case report : contexte sanitaire Covid-19, un risque supplémentaire d’erreur médicamenteuse ?
title_full Case report : contexte sanitaire Covid-19, un risque supplémentaire d’erreur médicamenteuse ?
title_fullStr Case report : contexte sanitaire Covid-19, un risque supplémentaire d’erreur médicamenteuse ?
title_full_unstemmed Case report : contexte sanitaire Covid-19, un risque supplémentaire d’erreur médicamenteuse ?
title_short Case report : contexte sanitaire Covid-19, un risque supplémentaire d’erreur médicamenteuse ?
title_sort case report : contexte sanitaire covid-19, un risque supplémentaire d’erreur médicamenteuse ?
topic Article Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092491/
http://dx.doi.org/10.1016/j.phclin.2021.04.010
work_keys_str_mv AT abbesm casereportcontextesanitairecovid19unrisquesupplementairederreurmedicamenteuse
AT loprestic casereportcontextesanitairecovid19unrisquesupplementairederreurmedicamenteuse
AT bambinae casereportcontextesanitairecovid19unrisquesupplementairederreurmedicamenteuse
AT aghazarianv casereportcontextesanitairecovid19unrisquesupplementairederreurmedicamenteuse
AT honores casereportcontextesanitairecovid19unrisquesupplementairederreurmedicamenteuse